Monthly shot lowers cholesterol 66 percent: study
A monthly injection of an experimental drug made by the US biotech firm Amgen reduced patients' cholesterol by up to 66 percent, according to a small study described at a US cardiology conference.
Cardiology
Mar 26, 2012 |
5 / 5 (2) |
5
Statin use appears associated with modest reduction in Parkinson's disease risk
Regular use of cholesterol-lowering statin drugs may be associated with a modest reduction in risk for developing Parkinson disease, particularly among younger patients, according to a study in the March issue of Archives of ...
Parkinson's & Movement disorders
Mar 12, 2012 |
not rated yet |
0
|
Merck: FDA won't OK its combo cholesterol drug now
(AP) -- Federal regulators have rejected Merck & Co.'s new combination cholesterol drug, which includes a generic version of the mega-blockbuster Lipitor - at least for now.
Medications
Mar 05, 2012 |
not rated yet |
0
American Heart Association comment: FDA announces safety changes on labeling for some statins
The United States Food and Drug Administration (FDA) announced it is revising safety information on the labels of some statins (cholesterol lowering drugs).
Cardiology
Feb 29, 2012 |
not rated yet |
0
FDA adds new safety information to statin drugs
(AP) -- Federal health officials are adding new safety warnings about risks of memory loss and elevated blood sugar to statins, a widely prescribed group of cholesterol-lowering medications.
Medications
Feb 28, 2012 |
not rated yet |
0
Lessons from $800-million drug flop may lead to a new genre of anti-cholesterol medicines
Mindful of lessons from a failed heart drug that cost $800 million to develop, drug companies are taking another shot at new medications that boost levels of so-called "good cholesterol," which removes cholesterol from the ...
Medications
Feb 22, 2012 |
not rated yet |
0
Websites advertising cholesterol-lowering drugs of poor quality
A new study published in the journal Pharmacoepidemiology & Drug Safety reveals that internet sites selling prescription statins directly to consumers are widespread, and that most websites advertising statins for sale t ...
Medications
Feb 02, 2012 |
not rated yet |
0
Stop taking steroids: Kidney transplant recipients may not need long-term prednisone
Rapid discontinuation of the immunosuppressive steroid prednisone after a kidney transplant can help prevent serious side effects, according to a study appearing in an upcoming issue of the Clinical Journal of the American So ...
Other
Jan 26, 2012 |
not rated yet |
0
Multiple medicines may double fall rate for young and middle aged
(Medical Xpress) -- Working-age adults who take combinations of prescription medication may be doubling their risk of serious falls at home according to research from The University of Auckland.
Medications
Jan 23, 2012 |
not rated yet |
0
Study finds statin costs 400 percent higher in US compared to UK
In the United States, the cost paid for statins (drugs to lower cholesterol) in people under the age of 65 who have private insurance is approximately 400 percent higher than comparable costs paid by the government in the ...
Medications
Jan 05, 2012 |
3.7 / 5 (3) |
12
With new generic rivals, Lipitor's sales halved
Sales of cholesterol blockbuster Lipitor plunged by half barely a week after the world's top-selling drug got its first U.S. generic competition, new data show.
Medications
Dec 20, 2011 |
not rated yet |
3
US approves India's Ranbaxy to make generic Lipitor
Indian pharmaceutical giant Ranbaxy won US regulatory approval to make the first generic version of cholesterol lowering drug Lipitor, a Pfizer product whose patent expired Wednesday.
Medications
Dec 01, 2011 |
5 / 5 (1) |
0
Pfizer's blockbuster drug Lipitor goes generic
Pfizer's patent on the best-selling drug of all-time, the cholesterol-lowering medication Lipitor, expired on Wednesday, opening the path to generic competitors for America's most popular medication.
Medications
Nov 30, 2011 |
not rated yet |
1
Cholesterol levels elevated in toddlers taking anti-HIV drugs
(Medical Xpress) -- Toddlers receiving anti-HIV drugs have higher cholesterol levels, on average, than do their peers who do not have HIV, according to researchers at the National Institutes of Health and other institutions.
HIV & AIDS
Nov 22, 2011 |
not rated yet |
0
|
Heart experts share some surprising findings
A shot that could lower cholesterol, a connection between blood type and stroke, and how income affects heart health were among more than 4,000 papers presented this week at the American Heart Association's 84th annual scientific ...
Cardiology
Nov 21, 2011 |
not rated yet |
0
